Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
40.5M
-
Shares change
-
+1.93M
-
Total reported value, excl. options
-
$532M
-
Value change
-
+$24.3M
-
Put/Call ratio
-
0.35
-
Number of buys
-
66
-
Number of sells
-
-51
-
Price
-
$13.15
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q2 2018
154 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q2 2018.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.5M shares
of 157M outstanding shares and own 25.73% of the company stock.
Largest 10 shareholders include venBio Select Advisor LLC (4.95M shares), RA CAPITAL MANAGEMENT, LLC (4.28M shares), BlackRock Inc. (4.08M shares), STATE STREET CORP (3.71M shares), FMR LLC (3.57M shares), VANGUARD GROUP INC (2.79M shares), FRANKLIN RESOURCES INC (2.28M shares), BRIDGER MANAGEMENT, LLC (2.19M shares), WELLS FARGO & COMPANY/MN (889K shares), and NORTHERN TRUST CORP (752K shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.